Results for tag: "Crisaborole"

Crisaborole is a topical ointment used to treat mild to moderate atopic dermatitis (eczema). It is a phosphodiesterase-4 (PDE-4) inhibitor, which works by reducing inflammation and itching. It is available in both prescription and over-the-counter (OTC) forms. Crisaborole is the only PDE-4 inhibitor approved by the U.S. Food and Drug Administration (FDA) for the treatment of atopic dermatitis. The Crisaborole market is a rapidly growing segment of the dermatological drugs market. It is expected to benefit from the increasing prevalence of atopic dermatitis, as well as the growing demand for OTC treatments. The market is also expected to benefit from the increasing awareness of the condition and the availability of new treatments. Some of the major companies in the Crisaborole market include Pfizer, Mylan, and GlaxoSmithKline. Other companies include Sun Pharmaceuticals, Novartis, and Merck. Show Less Read more